We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NPH:JSENortham Platinum Holdings Limited Analysis

Data as of 2026-05-22 - not real-time

ZAC 30,998.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Northam Platinum Holdings (NPH.JO) is trading at 30,998 ZAc, notably above its discounted cash flow fair value of 21,703 ZAc, indicating a price premium of roughly 43%. The stock sits below its 20‑day and 50‑day SMAs (33,750 and 34,662 respectively) and the 14‑day RSI of 38 signals modest oversold pressure, while a bearish MACD histogram reinforces short‑term downside momentum. Despite this technical weakness, the company reports robust fundamentals: revenue growth of 60%, operating margin near 25%, ROE of 26%, and a generous 4.5% dividend yield supported by a low payout ratio of 9.4%. Volatility is elevated at 57% (30‑day), yet beta is low (0.36), suggesting limited correlation with broader market swings.
The valuation landscape is mixed: a forward PE of 7.6x and forward EPS growth imply value potential, but the current price exceeds intrinsic estimates, flagging an overvalued stance. Liquidity appears healthy with rising volume and a sizable market cap, while sector‑specific risks—commodity price cycles and South African regulatory environment—remain material. Overall, the stock offers an attractive dividend and strong cash generation, but price pressure and sector volatility temper enthusiasm.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD histogram
  • Proximity to recent support level

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong cash flow and low dividend payout ratio
  • Forward PE compression indicating potential upside
  • Persistent overvaluation relative to DCF

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Long‑term demand for platinum group metals
  • Sustainable dividend yield with ample payout capacity
  • Solid ROE and operating margins supporting earnings growth

Key Metrics & Analysis

Financial Health

Revenue Growth60.00%
Profit Margin22.04%
P/E Ratio13.5
ROE26.32%
ROA8.56%
Debt/Equity30.60
P/B Ratio3.1
Op. Cash FlowZAC11.0B
Free Cash FlowZAC2.5B

Technical Analysis

TrendNeutral
RSI38.3
SupportZAC 30,691.00
ResistanceZAC 37,800.00
MA 20ZAC 33,750.50
MA 50ZAC 34,661.32
MA 200ZAC 31,570.01
MACDBearish
VolumeIncreasing
Fear & Greed Index91.45

Valuation

Fair ValueZAC 21,703.25
Target PriceZAC 40,392.13
Upside/Downside30.31%
GradeOvervalued
TypeBlend
Dividend Yield4.50%

Risk Assessment

Beta0.36
Volatility57.10%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.